International Stem Cell Corporation (ISCO)
OTCMKTS
· Delayed Price · Currency is USD
0.170
+0.020 (13.33%)
Apr 28, 2026, 4:00 PM EST
International Stem Cell Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 9.1 | 9.09 | 7.79 | 8.18 | 7.18 | Upgrade
|
| Revenue Growth (YoY) | 0.17% | 16.64% | -4.78% | 13.99% | 0.67% | Upgrade
|
| Cost of Revenue | 4.03 | 3.76 | 3.18 | 3.27 | 2.94 | Upgrade
|
| Gross Profit | 5.07 | 5.32 | 4.61 | 4.91 | 4.24 | Upgrade
|
| Selling, General & Admin | 5.24 | 5.17 | 5.2 | 5.05 | 5.9 | Upgrade
|
| Research & Development | 0.09 | 0.22 | 0.07 | 0.04 | 0.01 | Upgrade
|
| Operating Expenses | 5.33 | 5.39 | 5.27 | 5.09 | 5.91 | Upgrade
|
| Operating Income | -0.27 | -0.07 | -0.66 | -0.18 | -1.67 | Upgrade
|
| Interest Expense | -0.15 | -0.15 | -0.14 | -0.14 | -0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0 | 0.01 | -0.01 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -0.42 | -0.21 | -0.79 | -0.33 | -1.79 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.25 | Upgrade
|
| Other Unusual Items | - | - | 0.66 | - | 1.14 | Upgrade
|
| Pretax Income | -0.42 | -0.21 | -0.13 | -0.33 | -0.9 | Upgrade
|
| Net Income | -0.42 | -0.21 | -0.13 | -0.33 | -0.9 | Upgrade
|
| Net Income to Common | -0.42 | -0.21 | -0.13 | -0.33 | -0.9 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | - | - | - | 2.19% | 3.90% | Upgrade
|
| EPS (Basic) | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 | Upgrade
|
| Free Cash Flow | -0.04 | -0.15 | 0.85 | 0.33 | -1.32 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.02 | 0.11 | 0.04 | -0.17 | Upgrade
|
| Gross Margin | 55.68% | 58.57% | 59.16% | 60.04% | 59.10% | Upgrade
|
| Operating Margin | -2.93% | -0.75% | -8.51% | -2.24% | -23.29% | Upgrade
|
| Profit Margin | -4.59% | -2.30% | -1.68% | -4.05% | -12.53% | Upgrade
|
| Free Cash Flow Margin | -0.39% | -1.68% | 10.90% | 4.05% | -18.39% | Upgrade
|
| EBITDA | -0.05 | 0.14 | -0.47 | 0.04 | -1.41 | Upgrade
|
| EBITDA Margin | -0.53% | 1.52% | -6.02% | 0.43% | -19.63% | Upgrade
|
| D&A For EBITDA | 0.22 | 0.21 | 0.19 | 0.22 | 0.26 | Upgrade
|
| EBIT | -0.27 | -0.07 | -0.66 | -0.18 | -1.67 | Upgrade
|
| EBIT Margin | -2.93% | -0.75% | -8.51% | -2.24% | -23.29% | Upgrade
|
| Advertising Expenses | 0.1 | 0.18 | 0.2 | 0.22 | 0.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.